Utilidad de los anticuerpos anticitoplasma de neutrófilo en reumatología

Kussmaul, 1866, Ueber eine bisher nicht beschirebene eigenthuemliche Arterienerkrankung (Periarteritis nodosa), die mit Morbus Brightii uns rapid fortschreitender allgemeiner Muskellaehmung einhergeht, Deutsches Arch Klin Med, 1, 484 Van der Woude, 1985, Autoantibodies against neutrophils and monocytes: tools for diagnosis and marker of disease activity in Wegener's granulomatosis, Lancet, 1, 425, 10.1016/S0140-6736(85)91147-X Falk, 1988, Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis, New Engl J Med, 318, 1651, 10.1056/NEJM198806233182504 Nässberger, 1989, Circulating anti-neutrophil cytoplasm antibodies in patients with rapidly progressive glomerulonephritis and extracapillary proliferation, J Intern Med, 225, 191, 10.1111/j.1365-2796.1989.tb00062.x Niles, 1989, Wegener's granulomatosis autoantigen is a novel neutrophil serine protease, Blood, 74, 1888, 10.1182/blood.V74.6.1888.1888 Csernok, 1990, Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis, Am J Pathol, 137, 1113 Hagen, 1998, Diagnostic value of standarized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis, Kidney Int, 53, 743, 10.1046/j.1523-1755.1998.00807.x Savige, 1999, International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA), Am J Clin Pathol, 111, 507, 10.1093/ajcp/111.4.507 McLaren, 2001, The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting, QJM, 94, 615, 10.1093/qjmed/94.11.615 Mandl, 2002, Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis: can test-ordering guidelines improve diagnostic accuracy, Arch Intern Med, 162, 1509, 10.1001/archinte.162.13.1509 Flores-Suárez, 2008, Low yield of ANCA testing in a general referral centre: need for review including ANCA nomenclature [abstract], Ann Rheum Dis, 67, 226 Robinson, 2009, Appropriateness of antineutrophil cytoplasmic antibody testing in a tertiary hospital, J Clin Pathol, 62, 743, 10.1136/jcp.2009.064485 Arnold, 2010, Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patients, J Clin Pathol, 63, 678, 10.1136/jcp.2009.072504 Schmitt, 2004, Clinical applications of antineutrophil cytoplasmic antibody testing, Curr Opin Rheumatol, 16, 9, 10.1097/00002281-200401000-00004 Reumaux, 2003, Serological markers in inflammatory bowel diseases, Best Pract Res Clin Gastroenterol, 17, 19, 10.1053/bega.2002.0347 Preda, 2005, Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis, Rom J Gastroenterol, 14, 357 Trimarchi, 2001, Cocaine-induced midline destructive lesions: clinical, radiographic, histopathologic, and serologic features and their differentiation from Wegener's granulomatosis, Medicine, 80, 391, 10.1097/00005792-200111000-00005 Wiik, 2008, Drug-induced vasculitis, Curr Opin Rheumatol, 20, 35, 10.1097/BOR.0b013e3282f1331f Chung, 2011, Characteristic purpura of the ears, vasculitis, and neutropenia-a potential public health epidemic associated with levamisole-adulterated cocaine, J Am Acad Dermatol, 65, 722, 10.1016/j.jaad.2010.08.024 Bradford, 2010, Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole, Ann Intern Med, 152, 758, 10.7326/0003-4819-152-11-201006010-00026 Farhat, 2010, Levamisole-induced cutaneous necrosismimicking coagulopathy, Arch Dermatol, 146, 1320, 10.1001/archdermatol.2010.335 De la Hera, 2011, Necrosis of ears alter use of cocaine probably adulterated with levamisole, Dermatology, 223, 25, 10.1159/000329436 Graf, 2011, Purpura, cutaneous necrosis, and antineutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine, Arthritis Rheum, 63, 3998, 10.1002/art.30590 Rodrigues, 2011, A novel 60kDa reactivity in cyclic neutropenia: high titer cytoplasmic ANCA immunostaining pattern and negative anti-proteinase-3 antibody, Joint Bone Spine, 78, 319, 10.1016/j.jbspin.2010.10.001 Crichlow, 2011, Is IgA antineutrophil cytoplasmic antibody a marker for patient with erythema elevatum diutinum. A further three cases demonstrating this association, Br J Dermatol, 164, 675 Wiik, 2002, Neutrophil-specific autoantibodies in chronic inflammatory bowel diseases, Autoimmun Rev, 1, 67, 10.1016/S1568-9972(01)00007-6 Flores-Suárez, 2009, Laboratory investigation in the diagnosis of vasculitis, Curr Rheum Rep, 11, 395, 10.1007/s11926-009-0058-5 Sinico, 2005, Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome, Arthritis Rheum, 52, 2926, 10.1002/art.21250 Sablé-Fourtassou, 2005, Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome, Ann Intern Med, 143, 632, 10.7326/0003-4819-143-9-200511010-00006 Kain, 2008, Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis, Nat Med, 14, 1088, 10.1038/nm.1874 Roth, 2012, Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis, J Am Soc Nephrol, 23, 545, 10.1681/ASN.2011030273 Kawakami, 2012, Elevated anti-lysosomal-associated membrane protein-2 antibody levels in patients with adult Henoch-Schönlein purpura, Br J Dermatol, 166, 1206, 10.1111/j.1365-2133.2012.10884.x Tervaert, 1990, Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre, Lancet, 336, 706 Boomsma, 2000, Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels, Arthritis Rheum, 43, 2025, 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O Esnault, 1993, Association of ANCA isotype and affinity with disease expression, J Autoimmun, 6, 197, 10.1006/jaut.1993.1017 Nowack, 2001, A.N.C.A-titers even of IgG-subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis, Nephrol Dial Transpl, 16, 1631, 10.1093/ndt/16.8.1631 Birck, 2006, Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review, Am J Kidney Dis, 47, 15, 10.1053/j.ajkd.2005.09.022 Finkielman, 2007, Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis, Ann Intern Med, 147, 611, 10.7326/0003-4819-147-9-200711060-00005 Tomasson, 2012, Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis-a meta-analysis, Rheumatology, 51, 100, 10.1093/rheumatology/ker280 Holle, 2005, Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off, Ann Rheum Dis, 64, 1773, 10.1136/ard.2005.035279 Hellmich, 2007, A novel high sensitivity ELISA for detection of antineutrophil cytoplasm antibodies against proteinase-3, Clin Exp Rheumatol, 25, S1 Damoiseaux, 2007, Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease, Ann N Y Acad Sci, 1109, 454, 10.1196/annals.1398.051 Flores-Suárez, 2005, Do serial ANCA titres predict relapse in ANCA-associated vasculitis, Presse Med, 19, 1541 Slot, 2004, Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis, Arthritis Rheum, 51, 269, 10.1002/art.20234 Walsh, 2012, Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis, Arthritis Rheum, 64, 542, 10.1002/art.33361 Kälsch, 2010, Use of highly sensitive C-reactive protein for followup of Wegener‘s granulomatosis, J Rheumatol, 37, 2319, 10.3899/jrheum.100302 Schmitt, 2003, Organ transplantation in the vasculitides, Curr Opin Rheumatol, 15, 22, 10.1097/00002281-200301000-00005 Geetha, 2007, Renal transplantation in the ANCA-associated vasculitides, Am J Transplant, 7, 2657, 10.1111/j.1600-6143.2007.01988.x Geetha, 2010, Renal transplant in Wegener's granulomatosis compared to microscopic polyangiitis, J Rheumatol, 37, 1705, 10.3899/jrheum.091202 Woywodt, 2006, Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis, Ann Rheum Dis, 65, 164, 10.1136/ard.2005.040980 Erdbruegger, 2008, Diagnostic role of endothelial microparticles in vasculitis, Rheumatology, 47, 1820, 10.1093/rheumatology/ken373 Schneeweis, 2010, Increased levels of BLyS and VCAM-1 in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), Clin Exp Rheumatol, 28, 62 Bader, 2010, Nossent J. B-lymphocyte activating factor levels are increased in patients with Wegener‘s granulomatosis and inversely correlated with ANCA titer, Clin Rheumatol, 29, 1031, 10.1007/s10067-010-1526-z Nogueira, 2010, Serum IL-17 and IL-23 levels and autoantigen-specific TH-17 cells are elevated in patients with ANCA-associated vasculitis, Nephrol Dial Transplant, 25, 2209, 10.1093/ndt/gfp783 Hirayama, 2011, Serum ratio of soluble triggering receptor expressed on myeloid cells-1 to creatinine is a useful marker of infectious complications in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis, Nephrol Dial Transplant, 26, 868, 10.1093/ndt/gfq506 Berden, 2010, Anti-plasminogen antibodies compromise fibrinolysis and associate with renal histology in ANCA-associated vasculitis, J Am Soc Nephrol, 21, 2169, 10.1681/ASN.2010030274 Zwerina, 2011, Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study, Rheumatology, 50, 1823, 10.1093/rheumatology/keq445 Monach, 2011, Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis, Arthritis Rheum, 63, 3988, 10.1002/art.30615 Kümpers, 2009, Circulating angiopoietin-2 is a marker and potential mediator of endothelial cell detachment in ANCA-associated vasculitis with renal involvement, Nephrol Dial Transplant, 24, 1845, 10.1093/ndt/gfn755 Monach, 2012, Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis, PLoS One, 7, e30197, 10.1371/journal.pone.0030197 Zazueta-Montiel, 2011, Rutas y retos diagnósticos en vasculitis primarias, Reumatol Clin, 7, S1, 10.1016/j.reuma.2011.10.001